- Federal agenciesContinued federal support for agricultural genomics research and associated infrastructure.
- Potential benefitSustains jobs for researchers, data scientists, engineers, and support staff in ag research.
- Potential benefitMay accelerate development of disease‑resistant or higher‑yield crop and livestock varieties.
AG2PI Act of 2025
Referred to the House Committee on Agriculture.
This bill amends the Food, Agriculture, Conservation, and Trade Act of 1990 to reauthorize the Genome to Phenome Initiative (AG2PI). It extends the program authorization period through 2030 and reiterates support for research linking crop and livestock genomes to observable traits.
Left emphasizes climate resilience and open-data/public benefit
Relative to its intended legislative type, this bill is a narrowly focused administrative reauthorization that is well-specified in mechanism and clear in purpose but minimal in ancillary detail.
This bill amends the Food, Agriculture, Conservation, and Trade Act of 1990 to reauthorize the Genome to Phenome Initiative (AG2PI).
It extends the program authorization period through 2030 and reiterates support for research linking crop and livestock genomes to observable traits.
The text emphasizes interdisciplinary research networks, seed grants, and applying genomic-phenomic knowledge to improve agricultural resilience, productivity, and profitability.
Small, technical reauthorization of an established research program usually attracts bipartisan support, though lack of funding detail and competing floor priorities create uncertainty.
Relative to its intended legislative type, this bill is a narrowly focused administrative reauthorization that is well-specified in mechanism and clear in purpose but minimal in ancillary detail.
Left emphasizes climate resilience and open-data/public benefit
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Federal agenciesExtends federal program spending without specifying new funding offsets or amounts.
- CitiesBenefits may concentrate among larger firms or institutions with commercialization and IP capacity.
- Potential burdenRaises potential data privacy, ownership, and sharing concerns for genomic and phenotypic datasets.
Why the argument around this bill splits.
Left emphasizes climate resilience and open-data/public benefit
Likely supportive because the bill funds publicly led agricultural science that can advance resilience and sustainability.
It aligns with priorities on climate adaptation, public research, and supporting diverse researchers.
Concerns would focus on ensuring public-access data, benefits for small farmers, and guardrails against private capture.
Generally favorable if reauthorization is cost-effective and produces measurable results.
Views this as pragmatic investment in agricultural competitiveness and innovation.
Wants clear reporting, oversight, and demonstrated benefits for producers before deeper expansion.
Cautiously receptive if it clearly aids producers and avoids expanding federal bureaucracy.
Worries include added federal spending, potential regulatory follow-ons, and benefits flowing to large corporations.
Support depends on limits to scope and clear private-sector partnership roles.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Small, technical reauthorization of an established research program usually attracts bipartisan support, though lack of funding detail and competing floor priorities create uncertainty.
- No appropriation or cost estimate included
- Whether it will be considered standalone or attached to a larger bill
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Left emphasizes climate resilience and open-data/public benefit
Small, technical reauthorization of an established research program usually attracts bipartisan support, though lack of funding detail and…
Relative to its intended legislative type, this bill is a narrowly focused administrative reauthorization that is well-specified in mechanism and clear in purpose but minimal in ancillary detail.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.